Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
INTERCEPT PHARMACEUTICALS, INC. (ICPT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
10 Mar 2021
AKKARAJU SRINIVAS
Director
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
640,688
+58%
237,000
$21.17
$5,016,253.00
SELL
31 Dec 2020
Kapadia Sandip
CFO and Treasurer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
23,764
-8%
2,193
$24.47
$53,662.71
SELL
15 Dec 2020
Kapadia Sandip
CFO and Treasurer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
27,158
-6%
1,763
$32.78
$57,791.14
SELL
18 Aug 2020
Campagna Jason
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
8,778
-11%
1,192
$47.44
$56,542.52
SELL
13 Aug 2020
Genextra S.p.A.
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,235,512
-22%
1,500,000
$47.50
$71,248,660.00
SELL
13 Aug 2020
Fundaro Paolo
Director, 10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,235,512
-22%
1,500,000
$47.50
$71,248,660.00
SELL
13 Aug 2020
Micheli Francesco
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,235,512
-22%
1,500,000
$47.50
$71,248,660.00
SELL
13 May 2020
Genextra S.p.A.
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,500,000
-9%
595,578
$84.60
$50,385,896.00
SELL
13 May 2020
Fundaro Paolo
Director, 10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,500,000
-9%
595,578
$84.60
$50,385,896.00
SELL
13 May 2020
Micheli Francesco
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
5,500,000
-9%
595,578
$84.60
$50,385,896.00
SELL
27 Apr 2020
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
17,140
-1%
181
$85.95
$15,556.95
SELL
9 Apr 2020
Ford David A
Chief Human Resources Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
13,882
-0%
58
$70.00
$4,060.00
SELL
27 Feb 2020
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
17,367
-0%
113
$87.62
$9,901.06
SELL
23 Jan 2020
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
17,837
-3%
723
$94.04
$67,990.92
SELL
7 Jan 2020
Campagna Jason
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
6,303
-10%
732
$113.02
$82,730.64
SELL
31 Dec 2019
Ford David A
Chief Human Resources Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
10,580
-2%
259
$117.16
$30,344.44
SELL
31 Dec 2019
Cawkwell Gail
SVP, Med Affairs, Safety & PV, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
18,722
-1%
262
$125.00
$32,750.00
SELL
31 Dec 2019
Pruzanski Mark
President & CEO, Director, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
469,126
-0%
100
$125.00
$12,500.00
SELL
27 Dec 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
14,178
-10%
1,581
$123.24
$194,842.44
SELL
26 Dec 2019
Cawkwell Gail
SVP, Med Affairs, Safety & PV, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
18,722
-0%
54
$125.00
$6,750.00
SELL
26 Dec 2019
Pruzanski Mark
President & CEO, Director, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
469,126
-0%
417
$125.00
$52,125.00
SELL
19 Dec 2019
Campagna Jason
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
7,444
-2%
154
$119.45
$18,395.30
SELL
27 Nov 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
15,646
-6%
1,040
$101.65
$105,716.00
SELL
25 Nov 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
15,759
-28%
6,228
$100.00
$622,800.00
SELL
25 Nov 2019
Pruzanski Mark
President & CEO, Director, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
469,126
-9%
50,000
$100.00
$5,000,000.00
SELL
19 Nov 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
15,759
-8%
1,550
$85.00
$131,750.00
SELL
19 Nov 2019
Sullivan Ryan T
General Counsel and Secretary, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
25,718
-32%
12,154
$85.00
$1,033,090.00
SELL
13 Nov 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
17,309
-5%
946
$85.00
$80,410.00
SELL
13 Nov 2019
Sullivan Ryan T
General Counsel and Secretary, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
26,429
-1%
500
$85.00
$42,500.00
SELL
29 Oct 2019
Bright Lisa
President, International, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
18,732
-3%
595
$75.00
$44,625.00
SELL
23 Oct 2019
Ford David A
Chief Human Resources Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
11,396
-0%
58
$70.00
$4,060.00
SELL
16 Sep 2019
Ford David A
Chief Human Resources Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
11,546
-6%
800
$70.00
$56,000.00
BUY
28 Aug 2019
AKKARAJU SRINIVAS
Director
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
403,688
+1%
5,207
$60.32
$314,086.25
SELL
1 Jul 2019
Bright Lisa
President, International, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
19,857
-2%
595
$78.66
$46,802.70
BUY
14 May 2019
Benatti Luca
Director
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
7,556
+18%
1,200
$83.50
$100,200.00
SELL
1 May 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,499
-4%
2,000
$86.28
$172,560.00
SELL
15 Apr 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,499
-4%
2,000
$95.00
$190,000.00
SELL
1 Apr 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,499
-1%
562
$115.01
$64,635.62
SELL
1 Apr 2019
Bright Lisa
President, International, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
20,982
-2%
594
$115.01
$68,315.94
SELL
29 Mar 2019
Fundaro Paolo
Director
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
11,114
-16%
2,171
$107.45
$233,272.22
SELL
1 Mar 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
40,543
-4%
2,000
$103.16
$206,320.00
SELL
27 Feb 2019
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
19,107
-1%
333
$103.16
$34,352.28
SELL
19 Feb 2019
AKKARAJU SRINIVAS
Director
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
210,937
-10%
23,438
$128.78
$3,018,345.50
SELL
15 Feb 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
40,543
-4%
2,000
$111.51
$223,020.00
SELL
7 Jan 2019
Bright Lisa
President, International, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
18,807
-6%
1,313
$104.93
$137,773.10
SELL
4 Jan 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
37,243
-1%
474
$97.48
$46,205.52
SELL
1 Jan 2019
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
37,717
-6%
2,699
$98.07
$264,677.56
SELL
17 Dec 2018
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,152
-4%
2,000
$106.62
$213,240.00
SELL
3 Dec 2018
Bright Lisa
President, International, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
21,288
-19%
5,000
$111.42
$557,121.40
SELL
29 Nov 2018
Genextra S.p.A.
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
6,095,578
-10%
750,000
$105.07
$78,802,500.00
SELL
29 Nov 2018
Micheli Francesco
10% Owner
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
6,095,578
-10%
750,000
$105.07
$78,802,500.00
SELL
27 Nov 2018
Weyer Christian
EVP, Research & Development, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
15,819
-7%
1,343
$113.78
$152,806.53
SELL
15 Nov 2018
Pruzanski Mark
President & CEO, Director, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
584,581
-7%
50,000
$101.07
$5,053,713.00
SELL
1 Nov 2018
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,152
-4%
2,000
$96.32
$192,640.00
SELL
15 Oct 2018
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,152
-8%
3,425
$102.95
$352,603.75
SELL
5 Oct 2018
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
39,152
-1%
759
$110.65
$83,983.35
SELL
5 Sep 2018
Shapiro David
Chief Medical Officer, Officer
INTERCEPT PHARMACEUTICALS, INC.
(ICPT)
42,196
-10%
4,917
$111.43
$547,891.50
BUY
9 Apr 2018
Gottesdiener Keith Michael
Director
INTERCEPT PHARMACEUTICALS INC
(ICPT)
5,001
+30%
1,171
$64.00
$74,944.00
BUY
9 Apr 2018
Genextra S.p.A.
10% Owner
INTERCEPT PHARMACEUTICALS INC
(ICPT)
6,845,578
+6%
390,625
$64.00
$25,000,000.00
BUY
9 Apr 2018
Micheli Francesco
10% Owner
INTERCEPT PHARMACEUTICALS INC
(ICPT)
6,845,578
+6%
390,625
$64.00
$25,000,000.00
BUY
9 Apr 2018
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
576,564
+1%
7,812
$64.00
$499,968.00
BUY
9 Apr 2018
BRADBURY DANIEL
Director
INTERCEPT PHARMACEUTICALS INC
(ICPT)
11,642
+203%
7,812
$64.00
$499,968.00
SELL
2 Oct 2017
Kapadia Sandip
Chief Financial Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
20,215
-1%
354
$58.83
$20,826.74
SELL
2 Oct 2017
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
568,752
-0%
1,532
$58.87
$90,188.84
SELL
2 Oct 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,213
-0%
349
$58.90
$20,555.51
SELL
2 Oct 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
22,834
-1%
390
$58.92
$22,979.58
SELL
2 Oct 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
16,875
-1%
283
$58.89
$16,666.78
SELL
2 Oct 2017
Kim Richard J
SVP, Commercial US, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
11,205
-0%
48
$58.10
$2,788.80
SELL
1 Sep 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,562
-2%
1,250
$117.43
$146,787.50
SELL
25 Aug 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,324
-1%
253
$111.31
$28,161.33
SELL
2 Aug 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,477
-0%
142
$110.29
$15,660.73
SELL
1 Aug 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,562
-2%
1,118
$119.00
$133,042.00
SELL
31 Jul 2017
WELCH DANIEL G
Director
INTERCEPT PHARMACEUTICALS INC
(ICPT)
3,108
-16%
602
$123.93
$74,603.70
SELL
31 Jul 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,158
-0%
130
$123.12
$16,005.29
SELL
20 Jul 2017
WELCH DANIEL G
Director
INTERCEPT PHARMACEUTICALS INC
(ICPT)
3,710
-5%
217
$126.76
$27,506.92
SELL
14 Jul 2017
Kim Richard J
SVP, Commercial US, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
11,253
-0%
89
$128.64
$11,449.01
SELL
11 Jul 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,562
-1%
553
$124.01
$68,577.53
SELL
3 Jul 2017
Kapadia Sandip
Chief Financial Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
20,569
-6%
1,431
$121.59
$173,999.16
SELL
3 Jul 2017
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
570,284
-0%
1,434
$121.78
$174,632.52
SELL
3 Jul 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
45,215
-0%
350
$121.24
$42,435.00
SELL
3 Jul 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,619
-1%
394
$121.33
$47,802.05
SELL
3 Jul 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,288
-1%
257
$121.78
$31,297.46
SELL
3 Jul 2017
Kim Richard J
SVP, Commercial US, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
11,342
-0%
50
$121.69
$6,084.50
SELL
26 Jun 2017
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
603,902
-6%
40,000
$130.80
$5,231,863.50
SELL
1 Jun 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
24,613
-2%
698
$110.73
$77,288.75
SELL
25 May 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,246
-1%
254
$117.52
$29,850.26
SELL
16 May 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,600
-0%
113
$119.74
$13,530.79
SELL
2 May 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,378
-1%
426
$114.00
$48,564.00
SELL
1 May 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
45,465
-2%
1,117
$112.18
$125,305.06
SELL
1 May 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,545
-0%
114
$113.12
$12,895.69
SELL
10 Apr 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
45,465
-1%
558
$108.51
$60,548.58
SELL
3 Apr 2017
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
571,718
-0%
1.187
$115.00
$136.50
SELL
3 Apr 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
46,023
-0%
346
$115.00
$39,789.07
SELL
3 Apr 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
22,925
-1%
389
$115.00
$44,733.95
SELL
3 Apr 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,659
-1%
257
$115.00
$29,554.31
SELL
2 Mar 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
23,314
-5%
1,313
$130.16
$170,903.48
SELL
1 Mar 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
46,369
-2%
1,350
$128.66
$173,691.00
SELL
1 Mar 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
21,813
-0%
136
$130.16
$17,701.76
SELL
27 Feb 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
21,695
-1%
254
$119.48
$30,347.92
SELL
31 Jan 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,249
-0%
134
$108.96
$14,600.64
SELL
9 Jan 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
40,369
-3%
1,565
$106.01
$165,905.66
SELL
3 Jan 2017
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
552,705
-0%
2,802
$103.92
$291,181.30
SELL
3 Jan 2017
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
41,934
-2%
988
$103.92
$102,672.07
SELL
3 Jan 2017
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
17,090
-6%
1,119
$103.92
$116,285.47
SELL
3 Jan 2017
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
12,916
-5%
816
$103.92
$84,797.98
SELL
2 Dec 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
42,922
-3%
1,350
$99.75
$134,662.50
SELL
25 Nov 2016
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,209
-1%
249
$113.60
$28,286.25
SELL
14 Nov 2016
Bright Lisa
President International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,458
-0%
140
$112.27
$15,718.30
SELL
31 Oct 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
13,732
-0%
129
$123.82
$15,972.33
SELL
10 Oct 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,272
-0%
411
$153.34
$63,022.74
SELL
3 Oct 2016
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
552,020
-0%
705
$163.20
$115,055.80
SELL
3 Oct 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
44,846
-3%
1,513
$163.08
$246,732.55
SELL
3 Oct 2016
Duncan Barbara Gayle
Chief Accounting Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
30,661
-0%
147
$163.20
$23,990.36
SELL
3 Oct 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,305
-0%
155
$163.20
$25,295.96
SELL
26 Sep 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
45,732
-7%
3,545
$165.08
$585,199.70
SELL
20 Sep 2016
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
552,725
-5%
35,000
$165.00
$5,775,000.00
SELL
25 Aug 2016
Bright Lisa
President of International, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,460
-1%
246
$159.00
$39,114.00
SELL
1 Aug 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
13,861
-0%
125
$176.57
$22,070.63
SELL
5 Jul 2016
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
547,566
-0%
714
$145.11
$103,607.98
SELL
5 Jul 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
48,391
-0%
163
$145.11
$23,652.80
SELL
5 Jul 2016
Duncan Barbara Gayle
Chief Accounting Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
30,808
-0%
146
$145.11
$21,185.94
SELL
5 Jul 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,706
-0%
155
$145.11
$22,491.93
SELL
5 Jul 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
13,986
-0%
106
$145.11
$15,381.58
SELL
25 May 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
18,855
-1%
251
$137.50
$34,511.95
SELL
2 May 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
14,087
-0%
130
$147.49
$19,173.71
SELL
4 Apr 2016
Pruzanski Mark
CEO & President, Director, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
548,248
-0%
708
$130.76
$92,578.08
SELL
4 Apr 2016
Shapiro David
CMO and EVP - Development, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
48,546
-0%
165
$130.76
$21,575.40
SELL
4 Apr 2016
Duncan Barbara Gayle
Chief Financial Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
30,948
-0%
144
$130.76
$18,829.44
SELL
4 Apr 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
19,106
-0%
153
$130.76
$20,006.28
SELL
4 Apr 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
14,217
-0%
104
$130.76
$13,599.04
SELL
25 Feb 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
19,259
-1%
241
$115.22
$27,767.97
SELL
1 Feb 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
7,621
-1%
128
$103.56
$13,255.80
SELL
12 Jan 2016
Bright Lisa
See Remarks, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
11,700
-5%
728
$125.52
$91,380.81
SELL
4 Jan 2016
McMinn Rachel
Chief Strategy Officer, Officer
INTERCEPT PHARMACEUTICALS INC
(ICPT)
7,749
-5%
469
$145.90
$68,428.84
Home